Medivir to present at the Redeye Life Science Day
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Life Science Day on November 24, 2022. CEO Jens Lindberg will participate in an interview that will be broadcasted live at Redeye’s web site at 13.40 CET. On the event page you will find a pre-recorded company presentation as well as a form where you can post questions directly to us.The interview is live broadcasted and can be followed at the event page;